172 related articles for article (PubMed ID: 26257065)
1. Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.
Workenhe ST; Ketela T; Moffat J; Cuddington BP; Mossman KL
Oncogene; 2016 May; 35(19):2465-74. PubMed ID: 26257065
[TBL] [Abstract][Full Text] [Related]
2. Serine/Arginine-rich Splicing Factor 2 Modulates Herpes Simplex Virus Type 1 Replication via Regulating Viral Gene Transcriptional Activity and Pre-mRNA Splicing.
Wang Z; Liu Q; Lu J; Fan P; Xie W; Qiu W; Wang F; Hu G; Zhang Y
J Biol Chem; 2016 Dec; 291(51):26377-26387. PubMed ID: 27784784
[TBL] [Abstract][Full Text] [Related]
3. MiR-155-5p modulates HSV-1 replication via the epigenetic regulation of SRSF2 gene expression.
Wang Z; Li K; Wang X; Huang W
Epigenetics; 2019 May; 14(5):494-503. PubMed ID: 30950329
[TBL] [Abstract][Full Text] [Related]
4. Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.
Workenhe ST; Pol JG; Lichty BD; Cummings DT; Mossman KL
Cancer Immunol Res; 2013 Nov; 1(5):309-19. PubMed ID: 24777969
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.
Kulu Y; Kawasaki H; Donahue JM; Kasuya H; Cusack JC; Choi EW; Kuruppu DK; Fuchs BC; Tanabe KK
Cancer Gene Ther; 2013 Feb; 20(2):133-40. PubMed ID: 23348635
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
Israyelyan AH; Melancon JM; Lomax LG; Sehgal I; Leuschner C; Kearney MT; Chouljenko VN; Baghian A; Kousoulas KG
Hum Gene Ther; 2007 May; 18(5):457-73. PubMed ID: 17536976
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway.
Eisenberg DP; Carpenter SG; Adusumilli PS; Chan MK; Hendershott KJ; Yu Z; Fong Y
Surgery; 2010 Aug; 148(2):325-34. PubMed ID: 20633729
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.
Kolodkin-Gal D; Edden Y; Hartshtark Z; Ilan L; Khalaileh A; Pikarsky AJ; Pikarsky E; Rabkin SD; Panet A; Zamir G
Gene Ther; 2009 Jul; 16(7):905-15. PubMed ID: 19440231
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells.
Fasullo M; Burch AD; Britton A
Cell Cycle; 2009 Jul; 8(14):2194-7. PubMed ID: 19502787
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
Lee CY; Rennie PS; Jia WW
Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
[TBL] [Abstract][Full Text] [Related]
13. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
14. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype.
Fu X; Zhang X
Cancer Res; 2002 Apr; 62(8):2306-12. PubMed ID: 11956088
[TBL] [Abstract][Full Text] [Related]
15. Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.
Sobol PT; Boudreau JE; Stephenson K; Wan Y; Lichty BD; Mossman KL
Mol Ther; 2011 Feb; 19(2):335-44. PubMed ID: 21119618
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
17. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
[TBL] [Abstract][Full Text] [Related]
18. Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.
Wood LW; Shillitoe EJ
Cancer Gene Ther; 2011 Oct; 18(10):685-94. PubMed ID: 21701533
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation regulates arginine-rich RNA-binding protein solubility and oligomerization.
Kundinger SR; Dammer EB; Yin L; Hurst C; Shapley S; Ping L; Khoshnevis S; Ghalei H; Duong DM; Seyfried NT
J Biol Chem; 2021 Nov; 297(5):101306. PubMed ID: 34673031
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
Tan G; Kasuya H; Sahin TT; Yamamura K; Wu Z; Koide Y; Hotta Y; Shikano T; Yamada S; Kanzaki A; Fujii T; Sugimoto H; Nomoto S; Nishikawa Y; Tanaka M; Tsurumaru N; Kuwahara T; Fukuda S; Ichinose T; Kikumori T; Takeda S; Nakao A; Kodera Y
Int J Cancer; 2015 Apr; 136(7):1718-30. PubMed ID: 25156870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
